Selection in a biological context means the assortment of organisms due to their characteristics. On the one hand, this could be natural selection ("survival of the fittest") like in evolutionary processes. On the other hand, selection by man, e.g. breeding, is called artificial selection. Artificial selection is also used in genetic engineering to identify a genetically modified organism due to its new characteristics (e.g. resistance to antibiotics).
The EBDC is a two-day meeting that aims to bring a selected group of 120 business development executives from international pharmaceutical corporations and European biotech companies together with representatives from private equity and venture capital companies.
As always we will offer a sophisticated line-up of international speakers in four sessions focusing on the newest trends in therapeutic development. The EBCD programme also includes company presentations from innovative biotechs and of course provides conference partnering again.